Westfield Capital Management CO LP Fibrogen Inc Transaction History

Westfield Capital Management CO LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $18.3 Million - $33 Million	-591,464 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$37.09 - $48.97 $13.3 Million - $17.5 Million	358,268 Added 153.63%	591,464 $21.9 Million
Q3 2020 Nov 13, 2020	BUY	$40.47 - $45.5 $9.44 Million - $10.6 Million	233,196 New	233,196 $9.59 Million
Q4 2019 Feb 13, 2020	SELL	$34.58 - $48.06 $10.9 Million - $15.2 Million	-316,045 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$36.98 - $48.45 $279,272 - $365,894	7,552 Added 2.45%	316,045 $11.7 Million
Q2 2019 Aug 13, 2019	BUY	$35.13 - $55.53 $10.8 Million - $17.1 Million	308,493 New	308,493 $13.9 Million
Q4 2018 Feb 08, 2019	SELL	$37.97 - $60.16 $7.96 Million - $12.6 Million	-209,575 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $117,667 - $140,552	-2,090 Reduced 0.99%	209,575 $12.7 Million
Q2 2018 Aug 13, 2018	BUY	$44.9 - $64.95 $9.5 Million - $13.7 Million	211,665 New	211,665 $13.3 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.